0001104659-23-044168.txt : 20230411
0001104659-23-044168.hdr.sgml : 20230411
20230411191854
ACCESSION NUMBER: 0001104659-23-044168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230411
DATE AS OF CHANGE: 20230411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SELICK HAROLD E
CENTRAL INDEX KEY: 0001287233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 23814397
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm2312473-1_4seq.xml
OWNERSHIP DOCUMENT
X0407
4
2023-04-10
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001287233
SELICK HAROLD E
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
1
0
0
0
0
Common Stock
2023-04-10
4
M
0
6196
0.87
A
21506
D
Stock Option (right to buy)
0.87
2023-04-10
4
M
0
6196
0.00
D
2023-09-26
Common Stock
6196
0
D
The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.
The stock option is vested in full.
/s/ Asif Ali, Attorney-in-Fact for Harold E. Selick
2023-04-11